LONA earnings date and last-quarter result: last quarter beat, P/E -0.25. Updated 2026-07-23.
LeonaBio (LONA) Research Hub
LeonaBio (LONA) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 4.76 USD (-1.65%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.25, market cap 0.03B. This hub links to the full technical, earnings and options research available for LONA.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 4.76 USD (-1.65%) |
| 52-week range | 2.21 USD – 10.1 USD |
| Trend regime | Range |
| 14-day RSI | 37.3 (Bearish) |
| Trailing P/E | -0.25 |
| Market cap | 0.03B |
| Dividend yield | 0.00% |
Available research for LONA
Covered Call on LONA: how it works, illustrative setup around the real 4.76 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on LONA: how it works, illustrative setup around the real 4.76 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on LONA: how it works, illustrative setup around the real 4.76 USD price, max profit/loss, breakeven and when to use it. Educational.
LONA technical analysis: range, last 4.76 USD, RSI 37.3, 52w range 2.21 USD–10.1 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is LONA in?
LeonaBio (LONA) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is LONA in an uptrend or downtrend?
As of 2026-10-26, LONA is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is LONA's trailing P/E ratio?
LONA's trailing P/E is -0.25, with a market cap of 0.03B. See the earnings research page for full valuation detail.